These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 23610963
1. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides. Sypniewski D, Bednarek I, Gałka S, Loch T, Błaszczyk D, Sołtysik D. Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963 [Abstract] [Full Text] [Related]
2. [Changes in etoposide-induced apoptosis of HeLa tumor cells transfected with antisense oligonucleotide for BCL-2 mRNA]. Bednarek I, Sypniewski D, Solarz J, Machnik G, Gałka S, Loch T. Wiad Lek; 2008; 61(4-6):97-106. PubMed ID: 18939359 [Abstract] [Full Text] [Related]
3. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cioca DP, Aoki Y, Kiyosawa K. Cancer Gene Ther; 2003 Feb; 10(2):125-33. PubMed ID: 12536201 [Abstract] [Full Text] [Related]
4. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs]. Wang JQ, Du ZW, Gao XF, Wu M, Zhang YC, Pan Y, Wang Q, Zhang GZ. Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142 [Abstract] [Full Text] [Related]
5. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line. Joyner DE, Albritton KH, Bastar JD, Randall RL. J Orthop Res; 2006 Mar; 24(3):474-80. PubMed ID: 16450387 [Abstract] [Full Text] [Related]
6. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs. Tanabe K, Kim R, Inoue H, Emi M, Uchida Y, Toge T. Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082 [Abstract] [Full Text] [Related]
7. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells. Mewani RR, Tian S, Li B, Danner MT, Carr TD, Lee S, Rahman A, Kasid UN, Jung M, Dritschilo A, Gokhale PC. Int J Mol Med; 2006 Mar; 17(3):457-63. PubMed ID: 16465392 [Abstract] [Full Text] [Related]
8. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Floros KV, Thomadaki H, Florou D, Talieri M, Scorilas A. Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins. Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC. Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596 [Abstract] [Full Text] [Related]
10. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma. Aguirre D, Boya P, Bellet D, Faivre S, Troalen F, Benard J, Saulnier P, Hopkins-Donaldson S, Zangemeister-Wittke U, Kroemer G, Raymond E. Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422 [Abstract] [Full Text] [Related]
11. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Olie RA, Simões-Wüst AP, Baumann B, Leech SH, Fabbro D, Stahel RA, Zangemeister-Wittke U. Cancer Res; 2000 Jun 01; 60(11):2805-9. PubMed ID: 10850418 [Abstract] [Full Text] [Related]
12. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Sharma H, Sen S, Lo Muzio L, Mariggiò A, Singh N. Cancer Biol Ther; 2005 Jul 01; 4(7):720-7. PubMed ID: 15917659 [Abstract] [Full Text] [Related]
13. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells. Zangemeister-Wittke U, Leech SH, Olie RA, Simões-Wüst AP, Gautschi O, Luedke GH, Natt F, Häner R, Martin P, Hall J, Nalin CM, Stahel RA. Clin Cancer Res; 2000 Jun 01; 6(6):2547-55. PubMed ID: 10873111 [Abstract] [Full Text] [Related]
14. Bcl-2 gene silencing in pediatric epithelial liver tumors. Warmann SW, Frank H, Heitmann H, Ruck P, Herberts T, Seitz G, Fuchs J. J Surg Res; 2008 Jan 01; 144(1):43-8. PubMed ID: 17574594 [Abstract] [Full Text] [Related]
15. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Kausch I, Jiang H, Thode B, Doehn C, Krüger S, Jocham D. Eur Urol; 2005 May 01; 47(5):703-9. PubMed ID: 15826766 [Abstract] [Full Text] [Related]
16. [Modulation of bcl-2 antisense RNA on programmed cell death of leukemic cell line]. Chen X, Wang W, Huang G. Zhonghua Yi Xue Za Zhi; 1996 Feb 01; 76(2):112-5. PubMed ID: 8758442 [Abstract] [Full Text] [Related]
17. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers. Kitamura S, Kondo S, Shinomura Y, Kanayama S, Miyazaki Y, Kiyohara T, Hiraoka S, Matsuzawa Y. Br J Cancer; 2000 Sep 01; 83(5):668-73. PubMed ID: 10944610 [Abstract] [Full Text] [Related]
18. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Taylor JK, Zhang QQ, Wyatt JR, Dean NM. Nat Biotechnol; 1999 Nov 01; 17(11):1097-100. PubMed ID: 10545916 [Abstract] [Full Text] [Related]
19. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Yang G, Wu D, Zhu J, Jiang O, Shi Q, Tian J, Weng Y. Oncol Rep; 2013 Aug 01; 30(2):877-89. PubMed ID: 23760062 [Abstract] [Full Text] [Related]
20. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP]. Li M, Yu LL, Cai LQ, Wang HB, Wang ZH, Wang ZH. Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 01; 41(2):121-5. PubMed ID: 16640863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]